One of the world’s leading drug companies ‘plotted to destroy supplies of life-saving cancer medicines’ over a battle to drive up prices in Europe, it has been claimed.
South African firm Aspen Pharmacare is understood to have proposed the wastage during a row with the Spanish health service in 2014, while it is also said to have threatened to stop supplying medicine to Italian authorities a year earlier.
The price drive began after the firm, whose European headquarters is based in Dublin, bought the rights to five cancer medicines from British firm GlaxoSmithKline.
According to The Times, the company wanted to impose rises of up to 4,000 per cent after purchasing the ‘portfolio’ of drugs from GSK for more than £270million in 2009.
The paper reported that in 2013 the cost of leukaemia drug busulfan rose from £5.20 to £65.22 in England and Wales, a 1,100 per cent…
View original post 209 more words